More than a dozen letters of opposition have streamed in this week as the business community weighs in on HR 3309. The letters come from inventors, Higher Education (AAU, ACE, AAMC, APLU, AUTM, COGR), BioTech (BIO), Pharmaceutical Research and Manufacturers of America (PhRMA), Patent Office Professional Association (POPA), the American Bar Association (ABA), the Innovation Alliance and more.

Retired U. S.